New Key Statistics Module, Z-Score and F-Score
SZSE:300584 Key Ratios
Market Cap ¥ M | 2,661.60 |
Enterprise Value ¥ M | 2,946.30 |
P/E(ttm) | 63.37 |
PE Ratio without NRI | 55.45 |
Forward PE Ratio | -- |
Price/Book | 2.63 |
Price/Sales | 5.31 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.13 |
Revenue (TTM) ¥ M | 500.00 |
EPS (TTM) ¥ | 0.35 |
Beneish M-Score | -2.47 |
10-y EBITDA Growth Rate % | 8.40 |
5-y EBITDA Growth Rate % | -3.30 |
y-y EBITDA Growth Rate % | 43.50 |
EV-to-EBIT | 55.16 |
EV-to-EBITDA | 55.16 |
PEG | -- |
Shares Outstanding M | 120.00 |
Net Margin (%) | 8.40 |
Operating Margin % | 12.64 |
Pre-tax Margin (%) | 8.98 |
Quick Ratio | 0.78 |
Current Ratio | 1.05 |
ROA % (ttm) | 3.00 |
ROE % (ttm) | 4.22 |
ROIC % (ttm) | 4.53 |
Dividend Yield % | 0.23 |
Altman Z-Score | 5.03 |
SZSE:300584 Number of Guru Trades
SZSE:300584 Volume of Guru Trades
Gurus Latest Trades with SZSE:300584
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300584 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nanjing Hicin Pharmaceutical Co Ltd Insider Transactions
No Available Data